• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tis期膀胱癌完整光动力疗法的长期经验。

Long-term experience with integral photodynamic therapy of TIS bladder carcinoma.

作者信息

Jocham D, Beer M, Baumgartner R, Staehler G, Unsöld E

机构信息

Department of Urology of Ludwig-Maximillians-Universität, Klinikum Grosshadern, Munich, West Germany.

出版信息

Ciba Found Symp. 1989;146:198-205; discussion 205-8. doi: 10.1002/9780470513842.ch14.

DOI:10.1002/9780470513842.ch14
PMID:2534070
Abstract

Fifteen patients in whom superficial bladder tumours (TIS GII-III) recurred after the unsuccessful application of other treatments were treated by photodynamic therapy (PDT) and observed for 24-54 months. The results of therapy were evaluated by regular three-monthly check-ups (endoscopy, cytology, bladder mapping, renal ultrasonography) as well as by computed tomography (CT) examination at 8- to 13-month intervals. In nine patients treated by PDT no tumour recurrence has been found over the whole observation period. Two patients have remained free of tumour (12 and 14 months) after repeated transurethral resection (TUR) and Nd-YAG laser therapy after PDT. Two patients required a second application of PDT before the treatment goal was achieved. In one of these cases a circumscribed dysplasia which appeared at the left ostium 26 months after PDT was treated by TUR and Nd-YAG laser. Further observations showed it had been successfully removed. In six patients slight mucosal atypia persisted for at least 2.5 years. In the short-term course of further cases (n = 12) one cystectomy has to be performed because of bladder shrinkage. According to these preliminary results, PDT (with strict patient selection--worst-case situation with recommended cystectomy) is justified for recurrent superficial TIS bladder carcinoma.

摘要

15例浅表性膀胱肿瘤(Tis GII - III)在其他治疗方法应用失败后复发的患者接受了光动力疗法(PDT)治疗,并观察了24至54个月。通过每三个月定期检查(内镜检查、细胞学检查、膀胱绘图、肾脏超声检查)以及每隔8至13个月进行的计算机断层扫描(CT)检查来评估治疗结果。在接受PDT治疗的9例患者中,在整个观察期内未发现肿瘤复发。2例患者在PDT后经重复经尿道切除术(TUR)和Nd - YAG激光治疗后无肿瘤复发(分别为12个月和14个月)。2例患者在达到治疗目标前需要再次进行PDT治疗。其中1例患者在PDT后26个月时左侧开口处出现局限性发育异常,经TUR和Nd - YAG激光治疗。进一步观察表明已成功切除。6例患者轻微黏膜异型性持续至少2.5年。在更多病例(n = 12)的短期病程中,有1例因膀胱萎缩而进行了膀胱切除术。根据这些初步结果,对于复发性浅表性Tis膀胱癌,PDT(严格选择患者——最坏情况为推荐膀胱切除术)是合理的。

相似文献

1
Long-term experience with integral photodynamic therapy of TIS bladder carcinoma.Tis期膀胱癌完整光动力疗法的长期经验。
Ciba Found Symp. 1989;146:198-205; discussion 205-8. doi: 10.1002/9780470513842.ch14.
2
Clinical experience with the integral photodynamic therapy of bladder carcinoma.膀胱癌整体光动力疗法的临床经验
J Photochem Photobiol B. 1990 Jun;6(1-2):183-7. doi: 10.1016/1011-1344(90)85088-e.
3
Photodynamic therapy.光动力疗法
Urol Clin North Am. 1992 Aug;19(3):591-9.
4
[Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].[浅表性膀胱癌的光动力疗法。根治性膀胱切除术的替代方法?]
Urologe A. 1994 Jul;33(4):276-80.
5
Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.使用卟吩姆钠的光动力疗法作为膀胱原位难治性移行细胞癌患者膀胱切除术的替代方法。膀胱光卟啉研究组。
J Urol. 1998 Jul;160(1):39-44.
6
Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium.光动力疗法治疗难治性浅表性膀胱癌:使用膀胱内扩散介质单次治疗的长期临床结果
J Endourol. 2003 Oct;17(8):633-9. doi: 10.1089/089277903322518644.
7
Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.
Urology. 1985 Sep;26(3):274-80. doi: 10.1016/0090-4295(85)90125-6.
8
[Photodynamic therapy of superficial tumors and carcinoma in situ of the bladder].[浅表肿瘤及膀胱原位癌的光动力治疗]
Gan No Rinsho. 1985 May;31(6 Suppl):697-703.
9
Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder.全膀胱壁光动力疗法治疗难治性膀胱原位癌
Br J Cancer. 1995 Mar;71(3):625-8. doi: 10.1038/bjc.1995.122.
10
Complications of whole bladder dihematoporphyrin ether photodynamic therapy.全膀胱二血卟啉醚光动力疗法的并发症
J Urol. 1989 Jun;141(6):1341-6. doi: 10.1016/s0022-5347(17)41302-4.

引用本文的文献

1
The use of photodynamic therapy in medical practice.光动力疗法在医学实践中的应用。
Front Oncol. 2024 May 8;14:1373263. doi: 10.3389/fonc.2024.1373263. eCollection 2024.
2
Photodynamic Therapy: Current Trends and Potential Future Role in the Treatment of Bladder Cancer.光动力疗法:在膀胱癌治疗中的当前趋势和潜在未来作用。
Int J Mol Sci. 2024 Jan 12;25(2):960. doi: 10.3390/ijms25020960.
3
[Photodynamic therapy of bladder cancer. A new option].[膀胱癌的光动力疗法。一种新选择]
Urologe A. 2013 Sep;52(9):1225-32. doi: 10.1007/s00120-013-3306-2.
4
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.成像与光动力疗法:作用机制、监测与优化
Chem Rev. 2010 May 12;110(5):2795-838. doi: 10.1021/cr900300p.
5
Medical management of patients with refractory carcinoma in situ of the bladder.膀胱原位癌难治性患者的医学管理。
Drugs Aging. 2001;18(5):335-44. doi: 10.2165/00002512-200118050-00004.
6
Biological activities of phthalocyanines. XIV. Effect of hydrophobic phthalimidomethyl groups on the in vivo phototoxicity and mechanism of photodynamic action of sulphonated aluminium phthalocyanines.酞菁的生物活性。十四。疏水性邻苯二甲酰亚胺甲基基团对磺化铝酞菁体内光毒性及光动力作用机制的影响。
Br J Cancer. 1992 Jun;65(6):813-7. doi: 10.1038/bjc.1992.174.